Oruka Therapeutics Inc. (ORKA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Oruka Therapeutics Inc.

NASDAQ: ORKA · Real-Time Price · USD
15.20
0.15 (1.00%)
At close: Sep 26, 2025, 3:59 PM
15.03
-1.12%
After-hours: Sep 26, 2025, 06:38 PM EDT

Oruka Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
27K 111K 114K 91K
Gross Profit
-27K -111K -114K -91K
Operating Income
-88.12M -7.3M -9.84M -19.34M
Interest Income
5.86M 1.96M 675K n/a
Pretax Income
-83.72M -5.34M -9.93M -19.32M
Net Income
-83.72M -5.34M -9.93M -19.32M
Selling & General & Admin
13.04M 6.17M 5.26M 5.41M
Research & Development
75.06M 1.01M 4.46M 13.83M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
88.1M 7.18M 9.73M 19.24M
Interest Expense
1.47M n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
88.12M 7.3M 9.84M 19.34M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
16.79M 14.42M 14.41M 13.9M
Shares Outstanding (Diluted)
16.79M 14.42M 14.41M 13.9M
EPS (Basic)
-4.99 -4.44 -8.27 -16.68
EPS (Diluted)
-4.99 -4.44 -8.27 -16.68
EBITDA
-82.23M -5.23M -9.81M -19.23M
EBIT
-82.26M -5.34M -9.93M -19.32M
Depreciation & Amortization
27K 111K 114K 91K